Skip to main content
All lobbying filings

CGCN GROUP, LLC

Lobbying for PARTNER THERAPEUTICS, INC. · Biopharmaceutical company

 Filing 2nd Quarter - Report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 19, 2026
Income
$80,000.00
What the client paid this registrant for the period.
Client based in
Massachusetts

Official filing document

 Government bodies contacted 5
  • Defense, Dept of (DOD)
  • Health & Human Services, Dept of (HHS)
  • HOUSE OF REPRESENTATIVES
  • SENATE
  • White House Office

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

 Lobbying activity 2
Health Issues

Issues pertaining to the development of public health emergency medical countermeasures. Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act.

Defense

Issues related to medical countermeasures for Acute Radiation Syndrome (ARS).

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem